Clinical Trials Logo
  1. Home
  2. Immune System
  3. NCT05133128

An Experimental Medicine Clinical Study to Compare Peripheral Immune System From Subjects Without Cancer Diagnosis and Patients With Solid Tumours. — IMMUNOPBMC  

Immune System Clinical Trial

Official title:
An Experimental Medicine, Low Grade Interventional, Clinical Study to Compare Peripheral Immune System From Subjects Without Cancer Diagnosis and Patients With Advanced Solid Tumours

Clinical Trial Summary

The aim of the study is to gain knowledge concerning expression of immune markers on immune cell subpopulation of PBMCs from subjects without cancer diagnosis and cancer patients. Few studies have addressed the question of the difference of peripheric immune cells between these two populations without a specific focus on an immune cell population or an indication, and with a multiparametic approach. The present study will combine phenotypic (using cell population markers and immune checkpoints) and functional analyses toallow to better interpret non-clinical results obtained with either subjects without cancer or cancer patient material and provide rationale to use material from subjects without cancer diagnosis for functional tests. It would also argument a go to healthy volunteer's clinical trials for assessing peripheral pharmacodynamic (PD), receptor occupancy (RO) and safety (Cytokine release syndrome, CRS), in the context of early drug development in immuno-oncology. Finally, generated data will be used to feed quantitative system pharmacology (QSP) models to increase their robustness and better predict drug pharmacology in humans.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05133128
Study type Interventional
Source Servier
Contact
Status Terminated
Phase N/A
Start date November 25, 2021
Completion date July 21, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT02277080 - The Immune and Endocrine Systems in Chronic Non-cancer Patients Treated With Opioids
Active, not recruiting NCT05026242 - Effects of Almond Consumption on Innate and Adaptive Immune System N/A
Completed NCT04701502 - Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19 Phase 2
Recruiting NCT05792137 - Postprandial Monocyte Study N/A
Completed NCT05329337 - Link Between the Peripheral Mononuclear Cells' Capacity to Induce Insulin Resistance and Hyperinsulinemia N/A
Completed NCT06263686 - Evaluation of the Effects of Routine Intake of Fresh vs- Pasteurized Yoghurt on the Immune System in Healthy Adults N/A
Recruiting NCT04772794 - Immunologic Effect of Fraction of Inspired Oxygen N/A
Recruiting NCT06312423 - Safety and Pharmacokinetics of IMT504, an Immunomodulator and Tissue Repair Inducer Phase 1
Completed NCT00753402 - The Effects of Epinephrine in Endotoxemia in Normal Volunteers Phase 1
Completed NCT00820989 - Inflammation and the Host Response to Injury (In Healthy Volunteers) Phase 1
Completed NCT05221996 - Minimal-Dose Resistance Training for Improving sIgA and Cortisol N/A
Completed NCT04275440 - Effects of Caloric Restriction and Exercise on Body Weight, Immune Function, and Intestinal Flora N/A
Recruiting NCT06109337 - Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder
Recruiting NCT05648136 - Immune Profile Analysis and Biomarker Identification in Women With Repeated Implantation Failure or Unexplained Recurrent Spontaneous Miscarriage N/A
Completed NCT06190379 - Aromatherapy for Upper Respiratory Health N/A
Recruiting NCT05334888 - Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach
Completed NCT00730626 - Dose Response Study of a Fermented Yogurt on the Immune System and Gut Health N/A